Published on
16:11 GMT
Opinion: FDA clinical trial inclusivity guidelines will be back
Following the president’s recent executive order dismantling diversity, equity, and inclusion policies, the main page for the FDA’s Diversity Action Plan guidelines — requiring pharmaceutical companies to test drugs on diverse populations before approval — …
Source:
STAT - Massachusetts
-
Neutral
